Name: Latest research reports of Zydus Lifesciences Ltd. authored by Phillip Capital and published by - Trendlyne research reports.
Item: Zydus Lifesciences Ltd.
Rating: 3
Author: Phillip Capital

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

883.3000 -27.95 (-3.07%)

NSE May 20, 2025 15:31 PM

33.30% Fall from 52W High

Volume: 2.7M

High volume today

Zydus Lifesciences Ltd.

08 Feb 2016

883.30

-3.07%

Cadila 8Feb2016

Neutral: Zydus Lifesciences Ltd.

Target

Phillip Capital

9 CDH management is optimistic about the quick resolution of Warning Letter on its Moraiyaplant.ItexpectcontinuedUSgrowthmomentumledbynewlaunchesfromits recentlyUSFDAapprovedalternateplantsatBaddiandAhmadabadSEZ....

Zydus Lifesciences Ltd. is trading above its 30 day SMA of 875.8